Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002
Vaccine, Volume 25, No. SUPPL. 1, Year 2007
Notification
URL copied to clipboard!
Description
In 2001 a significant proportion of cases of meningococcal meningitis toward the end of a serogroup A epidemic in Niger and Burkina Faso was found to be caused by serogroup W135 meningococci. The World Health Organization put in place in several African countries an extended surveillance scheme in preparation for a possible epidemic situation. In January 2002, the first large epidemic of meningococcal disease caused by serogroup W135 started in Burkina Faso, resulting in more than 12,000 cases and 1400 deaths. We report here the results of the laboratory-based surveillance and the characteristics of the epidemic clone. © 2007 Elsevier Ltd. All rights reserved.
Authors & Co-Authors
Koumaré, Bréhima
Cote D'ivoire, Abidjan
Who Communicable Diseases Surveillance and Response
Ouédraogo-Traoré, Rasmata
Burkina Faso, Ouagadougou
Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle
Sanou, Idrissa
Burkina Faso, Ouagadougou
Centre Hospitalier Universitaire Yalgado Ouedraogo
Yada, Adamou A.
Zimbabwe, Harare
Who Regional Office for Africa
Sow, Idrissa
Zimbabwe, Harare
Who Regional Office for Africa
Lusamba, Paul Samson
Zimbabwe, Harare
Who Regional Office for Africa
Traoré, Etienne D.
Burkina Faso, Ouagadougou
World Health Organization Ouagadougou
Dabal, Moumouni
Burkina Faso, Ouagadougou
Ministere de la Sante Ouagadougou
Santamaria, Maria
Switzerland, Geneva
Organisation Mondiale de la Santé
Hacen, Mohamed Mahmoud
Burkina Faso, Ouagadougou
World Health Organization Ouagadougou
Kaboré, Antoine B.
Zimbabwe, Harare
Who Regional Office for Africa
Caugant, Dominique A.
Norway, Oslo
Who Collaborating Centre for Reference and Research on Meningococci
Statistics
Citations: 59
Authors: 12
Affiliations: 8
Identifiers
Doi:
10.1016/j.vaccine.2007.04.038
ISSN:
0264410X
Study Locations
Burkina Faso
Niger